|
|
Line 491: |
Line 491: |
|
| |
|
| =Staging breast cancer= | | =Staging breast cancer= |
| ==Sentinel lymph node sampling in breast cancer==
| | {{Main|Breast cancer staging}} |
| {{Main|Sentinel lymph node|Lymph node metastasis}} | |
| ===General===
| |
| *Selective sampling of lymph nodes.
| |
| *Used for staging.
| |
| *Positive LNs = poorer prognosis.
| |
| | |
| Notes:
| |
| *If there is no palpable disease, there is '''no''' mortality benefit from axillary lymph node dissection, i.e. positive axillary lymph nodes can be left in situ without affecting outcome.<ref>{{cite journal |author=Giuliano AE, Hunt KK, Ballman KV, ''et al.'' |title=Axillary dissection vs no axillary dissection in women with invasive breast cancer and sentinel node metastasis: a randomized clinical trial |journal=JAMA |volume=305 |issue=6 |pages=569–75 |year=2011 |month=February |pmid=21304082 |doi=10.1001/jama.2011.90 |url=}}</ref>
| |
| **This does not negate the fact that a positive sentinel LN biopsy (vs. negative sentinel LN biopsy) portends a poorer prognosis.
| |
| | |
| ===Microscopic===
| |
| Features:
| |
| *Atypical cells.
| |
| **Nuclear changes of malignancy:
| |
| ***Nuclear enlargement + variation in size.
| |
| ***Variation in shape.
| |
| ***Hyperchromasia and variation in staining.
| |
| **Usually in the subcapsular sinuses.
| |
| | |
| Pitfalls:
| |
| *Naevus cell rests.<ref>URL: [http://www.breastpathology.info/Case_of_the_month/2007/COTM_1107%20discussion.html http://www.breastpathology.info/Case_of_the_month/2007/COTM_1107%20discussion.html]. Accessed on: 28 November 2010.</ref>
| |
| | |
| ===IHC===
| |
| Some hospitals use:
| |
| *CAM5.2 (LMWK) - to look for isolated tumour cells and small lymph node metstases.
| |
| | |
| ==N stage==
| |
| Sampling usually selective, i.e. [[sentinel lymph nodes]] only.
| |
| ===Indications for lymph node sampling===<ref>URL: [http://www.cap.org/apps/docs/committees/cancer/cancer_protocols/2009/InvasiveBreast_09protocol.pdf http://www.cap.org/apps/docs/committees/cancer/cancer_protocols/2009/InvasiveBreast_09protocol.pdf]. Accessed on: 2 April 2012.</ref>
| |
| *Extensive [[DCIS]].
| |
| *Biopsy suspicious for invasion ''or'' with microinvasion.
| |
| *Clinical findings (large palable mass) or radiology findings (irregular features) suggestive of invasion.
| |
| *Planned mastectomy.
| |
| | |
| ===Definitions===
| |
| Definitions:<ref name=acs_website>URL: [http://www.cancer.org/Cancer/BreastCancer/DetailedGuide/breast-cancer-staging http://www.cancer.org/Cancer/BreastCancer/DetailedGuide/breast-cancer-staging]. Accessed on: 8 July 2010.</ref>
| |
| *Isolated tumour cells: <=0.2 mm ''or'' <=200 cells -- in a single cross-section. †
| |
| *Micrometastasis: <=0.2 cm ''and'' ( >0.2 mm ''or'' >200 cells ).
| |
| *Macrometastasis: >0.2 cm.
| |
| | |
| Notes:
| |
| * † The ''American Cancer Society'' web site says "or".<ref name=acs_website/> The CAP protocol says "and/or" and notes it is all subjective.
| |
| *Isolated tumour cells are essentially ignored if the there is at least one macrometastasis.
| |
| | |
| ===Details===
| |
| Lymph nodes:<ref>URL: [http://www.cancer.org/Cancer/BreastCancer/DetailedGuide/breast-cancer-staging http://www.cancer.org/Cancer/BreastCancer/DetailedGuide/breast-cancer-staging]. Accessed on: 8 July 2010.</ref>
| |
| *pN0: nil.
| |
| **pN0(i+): <=0.2 mm ''and'' <200 cells.
| |
| *pN1: 1-3 axillary LNs ''or'' internal mammary LNs.
| |
| **pN1mi: <=0.2 cm ''and'' ( >0.2 mm ''or'' >=200 cells ).
| |
| **pN1a.
| |
| **pN1b.
| |
| **PN1c.
| |
| *pN2 4-9 positive LNs; internal mammary LNs ''or'' axillary LNs.
| |
| *pN3.
| |
| | |
| ==T stage==
| |
| Tumour:<ref>URL: [http://www.cancer.org/Cancer/BreastCancer/DetailedGuide/breast-cancer-staging http://www.cancer.org/Cancer/BreastCancer/DetailedGuide/breast-cancer-staging]. Accessed on: 8 July 2010.</ref><ref>URL: [http://www.cancerhelp.org.uk/type/breast-cancer/treatment/tnm-breast-cancer-staging http://www.cancerhelp.org.uk/type/breast-cancer/treatment/tnm-breast-cancer-staging]. Accessed on: 9 July 2010.</ref>
| |
| *pT1: <= 20 mm.
| |
| **pT1mic <= 1 mm.
| |
| **pT1a > 1 mm ''and'' <= 5 mm.
| |
| **pT1b > 5 mm ''and'' <= 10 mm.
| |
| **pT1c > 10 mm ''and'' <= 20 mm.
| |
| *pT2: > 20 mm and <= 50 mm
| |
| *pT3: > 50 mm.
| |
| *pT4: chest wall or skin involvement.
| |
| | |
| Notes:
| |
| *Values should be rounded to the nearest millimetre.
| |
| **Therefore:
| |
| ***1.4 mm would be ''pT1mic''.
| |
| ***1.5 mm would be ''pT1a''.
| |
| | |
| ==M stage==
| |
| Distant metastasis:
| |
| *cM0(i+) <=0.2 mm focus of tumour cells, without clinical signs and symptoms.
| |
| *pM1 focus of tumour cells > 0.2 mm.
| |
|
| |
|
| =Lymphovascular invasion= | | =Lymphovascular invasion= |